Losartan Potassium And Hydrochlorothiazide
Product Images NDC 61919-040

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Losartan Potassium And Hydrochlorothiazide (NDC 61919-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label2)

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 50/12.5 mg tablets label by Direct Rx. The label indicates the product contains 90 tablets, each with 50 mg losartan potassium and 12.5 mg hydrochlorothiazide. It is a generic for Hyzaar and includes warnings about potential side effects such as dizziness, dry mouth, tiredness, and headaches. The packaging lists lot, expiration date (12/16), and NDC 61919-040-90.*

FDA Label Image

Image Description (Module 1)

Chemical structure of the active ingredient in LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, showing the molecular arrangement including chlorine, potassium ion, and other functional groups characteristic of losartan potassium.*

FDA Label Image

Image Description (Module 2)

Chemical structure diagram of the active ingredient Losartan Potassium, showing its molecular bonds and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.